Related references
Note: Only part of the references are listed.Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target
Margaret A. Knowles
WORLD JOURNAL OF UROLOGY (2007)
FGFR3 mutations in benign skin tumors
Christian Hafner et al.
CELL CYCLE (2006)
Receptor specificity of the fibroblast growth factor family - The complete mammalian FGF family
Xiuqin Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Cell responses to FGFR3 signalling:: growth, differentiation and apoptosis
CGM L'Hôte et al.
EXPERIMENTAL CELL RESEARCH (2005)
Cellular signaling by fibroblast growth factor receptors
VP Eswarakumar et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074
EK Grand et al.
LEUKEMIA (2004)
Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours
K Sibley et al.
ONCOGENE (2001)
Identification of a new fibroblast growth factor receptor, FGFR5
M Sleeman et al.
GENE (2001)
A novel alternatively spliced fibroblast growth factor receptor 3 isoform lacking the acid box domain is expressed during chondrogenic differentiation of ATDC5 cells
A Shimizu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma
M Chesi et al.
BLOOD (2001)
FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors
SH Ong et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization
J Schlessinger et al.
MOLECULAR CELL (2000)
Share Paper
